Trauma News and Research RSS Feed - Trauma News and Research

JPRAS Open: New open access journal from Elsevier

JPRAS Open: New open access journal from Elsevier

Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new, online-only open access journal, JPRAS Open . [More]
Worst effects of reperfusion injury after heart attack may be prevented with iodide

Worst effects of reperfusion injury after heart attack may be prevented with iodide

Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years. [More]
BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

BioElectronics to present innovative chronic pain therapy at OTC Pharma Asia Conference

BioElectronics Corporation, the maker of advanced consumer and healthcare medical devices announced today that its Executive Vice President, Dr. Deepak Kotak has been invited to present BioElectronics' innovative chronic pain therapy at the OTC Pharma Asia Conference, on Tuesday, March 3, 2015 in Singapore. [More]
Hemp Health launches CBD wellness supplements

Hemp Health launches CBD wellness supplements

Hemp Health Inc., a pioneer in hemp cannabidiol (CBD) products, today launched their line of CBD wellness supplements. Available in oil, spray and capsule form, Hemp Health's products offer a compelling alternative to medical marijuana. The CBD supplements provide consumers with the therapeutic ingredient in hemp while allowing them to avoid the negative mental and physical effects of marijuana. [More]
Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen enrolls first patient in Phase 1/2 clinical trial of RUT58-60

Ruthigen, Inc., announced today enrollment of the first patient in a Randomized, Double-Blind Phase 1/2 clinical trial to evaluate the safety, tolerability, and potential efficacy of its lead drug candidate, RUT58-60, for use as an adjunct to systemic antibiotics in abdominal surgery. [More]
New therapy appears to help tinnitus patients cope better with phantom noise

New therapy appears to help tinnitus patients cope better with phantom noise

Patients with tinnitus hear phantom noise and are sometimes so bothered by the perceived ringing in their ears, they have difficulty concentrating. A new therapy does not lessen perception of the noise but appears to help patients cope better with it in their daily lives, according to new research. [More]

New Ethicon stapling solution provides least tissue slippage during firing

Ethicon announced today the launch of the ECHELON FLEX GST SYSTEM, a new powered stapler and reload system uniquely designed to provide a better grip on tissue for the least tissue slippage during firing. The device will be featured at The American College of Surgeons Clinical Conference in San Francisco this week. [More]
Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Clementia initiates Phase 2 extension study of palovarotene in FOP patients

Clementia Pharmaceuticals, Inc. announced today the initiation of a Phase 2 extension study of palovarotene in patients with fibrodysplasia ossificans progressiva (FOP), a rare, severely disabling genetic disease characterized by painful, recurrent episodes of soft tissue swelling (flare-ups) and new abnormal bone formation. [More]
MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research announces acquisition of Jasper Clinical Research & Development

MPI Research today announced it has acquired the assets of Kalamazoo, Mich.-based Jasper Clinical Research & Development, Inc. Jasper is a respected clinical research organization that provides early-stage human clinical testing of promising new drugs, and is well known to pharmaceutical and biotechnology companies worldwide. [More]
Minnesota hospitals, health systems develop coordinated strategy to care for Ebola patients

Minnesota hospitals, health systems develop coordinated strategy to care for Ebola patients

The Minnesota Hospital Association announced today that hospitals and health systems from around the state have developed a coordinated strategy to care for Ebola patients in Minnesota. Under the plan, all hospitals in the state will continue to be prepared to detect, isolate and initially care for suspected Ebola patients. [More]
Helping children understand Ebola

Helping children understand Ebola

It dominates the headlines and is striking fear and panic in many communities around the world, Ebola. The constant barrage of information and so much unknown can be especially difficult for children, making it all the more important for parents to help their kids feel safe and to have a dialogue with them at the appropriate developmental level. [More]
Rutgers scientists are developing new medical imaging method for early detection of cancer

Rutgers scientists are developing new medical imaging method for early detection of cancer

A new medical imaging method being developed at Rutgers University could help physicians detect cancer and other diseases earlier than before, speeding treatment and reducing the need for invasive, time-consuming biopsies. [More]
Researchers find frequency, severity of medication errors among young children

Researchers find frequency, severity of medication errors among young children

According to Nationwide Children's Hospital researchers, 63,000 children under the age of six experienced out-of-hospital medication errors annually between 2002 and 2012. One child is affected every eight minutes, usually by a well-meaning parent or caregiver unintentionally committing a medication error. [More]
New SPANS assessment can help patients recover from traumatic brain injuries

New SPANS assessment can help patients recover from traumatic brain injuries

A dynamic new assessment for helping victims of trauma to the brain, including those suffering from progressive conditions such as dementia, has been developed by a clinical neuropsychologist at the University of Leicester. [More]
NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

NICO, Synaptive Medical join forces to integrate innovative technologies for brain surgery

Indianapolis interventional medical device maker NICO Corporation and Toronto-based 3D visualization leader Synaptive Medical announced today at the Congress of Neurological Surgeons Annual Meeting that they have joined forces to integrate their innovative technologies for brain surgery. [More]
Researchers uncover surprising way to reduce brain damage caused by head injuries

Researchers uncover surprising way to reduce brain damage caused by head injuries

Scientists have uncovered a surprising way to reduce the brain damage caused by head injuries - stopping the body's immune system from killing brain cells. The study, published in the open access journal Acta Neuropathologica Communications, showed that in experiments on mice, an immune-based treatment reduced the size of brain lesions. [More]
Research: Ageing and depression are associated with epigenetic changes

Research: Ageing and depression are associated with epigenetic changes

Psychological stress and stress-related psychiatric disorders are associated with increased risk for aging-related diseases, but the molecular mechanisms underlying this relation are unknown. [More]
MMP-3 disrupts brain/spinal cord barrier, promotes hemorrhage

MMP-3 disrupts brain/spinal cord barrier, promotes hemorrhage

Traumatic spinal cord injury (SCI) is a devastating condition with few treatment options. Studies show that damage to the barrier separating blood from the spinal cord can contribute to the neurologic deficits that arise secondary to the initial trauma. Through a series of sophisticated experiments, researchers reporting in The American Journal of Pathology suggest that matrix metalloproteinase-3 (MMP-3) plays a pivotal role in disruption of the brain/spinal cord barrier (BSCB), cell death, and functional deficits after SCI. [More]
Clinical study of Proxima miniature in-line blood gas analyser meets primary end point

Clinical study of Proxima miniature in-line blood gas analyser meets primary end point

Sphere Medical, innovator in critical care monitoring and diagnostics equipment, is pleased to announce the completion of a successful clinical study of its new Proxima miniature in-line blood gas analyser at the Queen Elizabeth Hospital, Birmingham, UK. [More]
Study: More interventions needed for people with severe mental illnesses in criminal justice system

Study: More interventions needed for people with severe mental illnesses in criminal justice system

Responding to the large number of people with serious mental illnesses in the criminal justice system will require more than mental health services, according to a new report. [More]